Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for pain reduction in sickle cell disease
NL-OMON28196Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in sickle cell disease (SCD) comparing N-acetylcysteine with Placebo comparator (2 arms). Primary endpoint: Frequency of SCD-related pain in daily life. Started Mar 2013; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NL-OMON28196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28196.